文献速递青光眼

小梁切除术与引流管植入术治疗葡萄膜炎性青光眼的有效性与安全性:系统综述与Meta分析

Effectiveness and Safety of Trabeculectomy Versus Tube Shunt Implantation for Uveitic Glaucoma: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Ophthalmol · 2024-09-16

该系统综述纳入8项研究,比较小梁切除术与青光眼引流装置(GDD)治疗葡萄膜炎性青光眼(UG)的疗效与安全性;两组眼压下降无显著差异(P=.48),但GDD组黄斑囊样水肿、翻修手术及葡萄膜炎发作率更高,小梁切除术组白内障进展风险更高。

要点

  • 小梁切除术与GDD在降低眼压方面无显著差异(P=.48)。
  • GDD组黄斑囊样水肿(15% vs. 4%,P<.001)、翻修手术(11% vs. 6%,P=.04)及葡萄膜炎发作(5% vs. 0%,P=.001)发生率更高。
  • 小梁切除术组白内障进展风险更高(7% vs. 1%,P<.001)。

核心结论

  • 小梁切除术与GDD在降低葡萄膜炎性青光眼患者眼压或减少抗青光眼药物方面疗效相当,但安全性特征存在显著差异。

研究设计与样本

  • 系统综述与Meta分析,检索七个电子数据库,纳入8项研究,共197眼行小梁切除术、277眼行GDD植入。
  • 采用随机效应模型进行Meta分析,使用美国国立卫生研究院质量评估工具评估偏倚风险。

主要发现

  • 小梁切除术组与GDD组眼压下降无显著差异(P=.48)。
  • 小梁切除术与Ahmed青光眼引流装置组(P=.38)或Baerveldt青光眼植入物组(P=.90)眼压下降均无显著差异。
  • GDD组黄斑囊样水肿发生率15% vs. 小梁切除术组4%(P<.001)。
  • GDD组翻修手术率11% vs. 小梁切除术组6%(P=.04);GDD组葡萄膜炎发作率5% vs. 小梁切除术组0%(P=.001)。
  • 小梁切除术组白内障进展风险7% vs. GDD组1%(P<.001)。

关键数值与推荐

  • 小梁切除术组平均年龄48.5岁,男性约53.5%;GDD组男性49.3%。
  • 主要结局为眼压下降,次要结局为术后并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effectiveness and safety of trabeculectomy compared to glaucoma drainage devices (GDDs) in managing uveitic glaucoma (UG). DESIGN: Systematic review. METHODS: We searched seven electronic databases (PubMed, Scopus, Web of Science, ScienceDirect, EMBASE, CENTRAL, and Google Scholar) to compare trabeculectomy with various GDDs in UG. The primary outcome was intraocular pressure (IOP) reduction, and secondary outcomes included postoperative complications. We fitted a random effects model for meta-analysis and assessed the risk of bias using the National Institute of Health quality assessment tool. RESULTS: We included eight studies; 197 eyes underwent trabeculectomy, and 277 eyes had GDDs. The mean age of participants was 48.5 years, with ∼53.5% being male in the trabeculectomy group and 49.3% in the GDDs group. The meta-analysis revealed no significant difference in IOP reduction between trabeculectomy and GDDs (P = .48). Subgroup analyses revealed no significant difference in IOP reduction between trabeculectomy and either the Ahmed glaucoma drainage device group (P = .38) or the Baerveldt glaucoma implant group (P = .90). GDDs were associated with higher rates of complications such as cystoid macular edema (CME) (15% vs. 4%, P < .001), need for revision surgery (11% vs. 6%, P = .04), and uveitic flare (5% vs. 0%, P = .001). However, trabeculectomy had a higher risk of cataract progression (7% vs. 1%, P < .001). CONCLUSION: Trabeculectomy and GDDs demonstrated comparable effectiveness in reducing IOP or glaucoma medication reduction in UG. However, there were significant differences in their safety profiles; CME and revisions were higher in GDD, and cataract progression was higher after trabeculectomy.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Serhan HA, Ba-Shammakh SA, Hassan AK, et al. Effectiveness and Safety of Trabeculectomy Versus Tube Shunt Implantation for Uveitic Glaucoma: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2024. PMID: 39293570. doi:10.1016/j.ajo.2024.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。